The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Sanofi SA

NYSE: SNY
Last

(U.S.) $48.34

Today's change0.00 0.00%
Updated March 4 4:02 PM EST. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $48.34

Today's change0.00 0.00%
Updated March 4 4:02 PM EST. Delayed by at least 15 minutes.

Sanofi SA closed at (U.S.)$48.34.

Shares have lost 4.11% over the last five days, but have gained 5.99% over the last year to date. This security has underperformed the S&P 500 by 19.01% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $48.34
  • High--
  • Low--
  • Bid / Ask(U.S.) $48.29 / (U.S.) $48.35
  • YTD % change+5.99%
  • Volume0
  • Average volume (10-day)1,572,457
  • Average volume (1-month)1,837,016
  • Average volume (3-month)2,474,725
  • 52-week range(U.S.) $43.57 to (U.S.) $57.42
  • Beta1.03
  • Trailing P/E25.93×
  • P/E 1 year forward15.47×
  • Forward PEG2.74×
  • Indicated annual dividend(U.S.) $1.62
  • Dividend yield3.35%
  • Trailing EPS(U.S.) $1.86
Updated March 4 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.37%

Based on its net profit margin of 13.37%, Sanofi SA is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue18,0388,8688,1467,925
Total other revenue--------
Total revenue18,0388,8688,1467,925
Gross profit12,1336,0045,5385,409
Total cost of revenue5,9052,8642,6082,516
Total operating expense14,5697,0846,9006,497
Selling / general / administrative4,7742,3092,2552,078
Research & development2,4971,1461,1881,139
Depreciation / amortization1,181561624677
Interest expense (income), net operating--------
Unusual expense (income)17615815554
Other operating expenses, total36467033
Operating income3,4691,7841,2461,428
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax3,1921,6451,1521,387
Income after tax2,6451,2648021,113
Income tax, total547381350274
Net income2,5291,1907771,084
Total adjustments to net income--------
Net income before extra. items2,5291,1907771,084
Minority interest-58-31-27-34
Equity in affiliates-58-4325
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,5291,1907771,084
Inc. avail. to common incl. extra. items2,5291,1907771,084
Diluted net income2,5291,1907771,084
Dilution adjustment--0----
Diluted weighted average shares1,3141,3131,3151,320
Diluted EPS excluding extraordinary itemsvalue per share1.920.910.590.82
Dividends per sharevalue per share1.580.000.000.00
Diluted normalized EPSvalue per share2.041.070.670.85